CLASS III Drug recall · Reported 5 Jun 2013 · FDA Enforcement Report

Lisinopril Tablets, USP, 30 mg recalled by Aurobindo Pharma USA

Aurobindo Pharma USA is recalling Lisinopril Tablets, USP, 30 mg, distributed nationwide in the US. The recall was initiated on 9 Apr 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13
NDC65862-037, 65862-038, 65862-039, 65862-040, 65862-041, 65862-042
UPC0365862037015, 0365862038012, 0365862040015
Quantity recalled1776 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-498-2013
FDA event ID
65071
Recalling firm
Aurobindo Pharma USA, Plainsboro, NJ
Manufacturer
Aurobindo Pharma Limited
Classification
Class III
Status
Terminated
Recall initiated
9 Apr 2013
FDA classified
30 May 2013
Reported
5 Jun 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Apr 2013Recall initiated by company
30 May 2013Classified by FDA+51 days
5 Jun 2013Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Product as listed by the FDA

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Which lots are affected?

Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aurobindo Pharma USA

All 59

Other Lisinopril recalls

All 38